Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study

Background: Acute leukemias are the most frequent malignancies in children. Advances in treatment have improved the overall survival to 80%. Almost 10% of children with cancer develop clinical cardiac toxicity. Total anthracycline cumulative dose is a risk factor for early-onset cardiotoxicity.Obje...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Colombia Médica
Main Authors: Adriana Linares Ballesteros, Roy Sanguino Lobo, Juan Camilo Villada Valencia, Oscar Arévalo Leal, Diana Constanza Plazas Hernández, Nelson Aponte Barrios, Iván Perdomo Ramírez
Formato: Artigo
Idioma:Inglês
Publicado em: Universidad del Valle 2021
Assuntos:
Medicina
Child
leukemia
drug therapy
anthracyclines
echocardiography
Acesso em linha:https://www.redalyc.org/articulo.oa?id=28366572004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados